{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:49:13Z","timestamp":1792190953756,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangsu Basic Research Program","award":["BK20161298"],"award-info":[{"award-number":["BK20161298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovarian syndrome (PCOS) is a multi-gene hereditary disorder caused by the interaction of certain gene variation with environmental factors. Previous studies have shown that vascular endothelial growth factor (VEGF) gene polymorphisms are associated with the risk of polycystic ovarian syndrome. However, the results of these studies remain controversial. We performed the present meta-analysis aiming to further investigate the potential relationship between VEGF polymorphisms and susceptibility to PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The following databases were systematically searched: PubMed, EMBASE, Web of Science (WOS), China National Knowledge Infrastructure (CNKI), and Wanfang Databases. The correlation between VEGF polymorphisms and PCOS risk was assessed by calculating pooled odds ratios (ORs) and their 95% confidence intervals (95% CIs). Subgroup analyses stratified by ethnicity and source of control were also conducted. Besides, trial sequential analysis (TSA) was done to verify the reliability of the pooled results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>10 relevant case-control studies were incorporated in this meta-analysis, involving 1347 PCOS cases and 1378 controls. The VEGF rs2010963 polymorphism was associated with decreased PCOS risk in the whole population and the Asian populations. The VEGF rs3025039 polymorphism was associated with decreased PCOS susceptibility and the Asian populations, but increased risk of PCOS was observed among the Caucasian populations. In addition, the results of trial sequential analysis (TSA) showed the negative correlation between rs2010963 and PCOS risk, obtained by our meta-analysis, was stable and reliable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, different VEGF gene polymorphisms may exert different effects on PCOS susceptibility. The VEGF rs2010963 polymorphism decreases PCOS susceptibility in both the whole population and the Asian populations, and VEGF rs3025039 polymorphism causes lower PCOS susceptibility in the whole population and the Asian populations but higher in the Caucasian populations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-020-00577-0","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:02:50Z","timestamp":1584021770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Jiahui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"9","key":"577_CR1","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"577_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","volume":"18","author":"R Hart","year":"2004","unstructured":"Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstetrics Gynaecol. 2004;18(5):671\u201383.","journal-title":"Best Pract Res Clin Obstetrics Gynaecol"},{"issue":"8","key":"577_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pena AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocrine Soc. 2019;3(8):1545\u201373.","journal-title":"J Endocrine Soc"},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000341679","volume":"40","author":"S Catteau-Jonard","year":"2013","unstructured":"Catteau-Jonard S, Dewailly D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. Front Horm Res. 2013;40:22\u20137.","journal-title":"Front Horm Res"},{"issue":"39","key":"577_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7748\/ns.2017.e10595","volume":"31","author":"P Cunningham","year":"2017","unstructured":"Cunningham P. Pathophysiology, diagnosis and treatment of polycystic ovary syndrome. Nurs Stand. 2017;31(39):44\u201351.","journal-title":"Nurs Stand"},{"issue":"1","key":"577_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1385\/ENDO:30:1:27","volume":"30","author":"A Gorry","year":"2006","unstructured":"Gorry A, White DM, Franks S. Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment. Endocrine. 2006;30(1):27\u201333.","journal-title":"Endocrine."},{"issue":"3","key":"577_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","volume":"89","author":"Thessaloniki EA-SPCWG","year":"2008","unstructured":"Thessaloniki EA-SPCWG. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89(3):505\u201322.","journal-title":"Fertil Steril"},{"issue":"3","key":"577_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/humrep\/15.3.612","volume":"15","author":"R Rai","year":"2000","unstructured":"Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage--a reappraisal. Hum Reprod. 2000;15(3):612\u20135.","journal-title":"Hum Reprod"},{"issue":"5","key":"577_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064446","volume":"8","author":"P Chakraborty","year":"2013","unstructured":"Chakraborty P, Goswami SK, Rajani S, Sharma S, Kabir SN, Chakravarty B, et al. Recurrent pregnancy loss in polycystic ovary syndrome: role of hyperhomocysteinemia and insulin resistance. PLoS One. 2013;8(5):e64446.","journal-title":"PLoS One"},{"issue":"2","key":"577_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrendo.2015.230","volume":"12","author":"R Azziz","year":"2016","unstructured":"Azziz R. PCOS in 2015: new insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol. 2016;12(2):74\u20135.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"577_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14737159.2017.1340833","volume":"17","author":"K Mykhalchenko","year":"2017","unstructured":"Mykhalchenko K, Lizneva D, Trofimova T, Walker W, Suturina L, Diamond MP, et al. Genetics of polycystic ovary syndrome. Expert Rev Mol Diagn. 2017;17(7):723\u201333.","journal-title":"Expert Rev Mol Diagn"},{"issue":"3","key":"577_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0034-1371089","volume":"32","author":"CK Welt","year":"2014","unstructured":"Welt CK, Duran JM. Genetics of polycystic ovary syndrome. Semin Reprod Med. 2014;32(3):177\u201382.","journal-title":"Semin Reprod Med"},{"key":"577_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000341682","volume":"40","author":"TM Barber","year":"2013","unstructured":"Barber TM, Franks S. Genetics of polycystic ovary syndrome. Front Horm Res. 2013;40:28\u201339.","journal-title":"Front Horm Res"},{"issue":"2","key":"577_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0006-291X(89)92678-8","volume":"161","author":"N Ferrara","year":"1989","unstructured":"Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161(2):851\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"577_CR15","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1158\/1078-0432.CCR-12-1315","volume":"18","author":"L Eng","year":"2012","unstructured":"Eng L, Azad AK, Habbous S, Pang V, Xu W, Maitland-van der Zee AH, et al. Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis. Clin Cancer Res. 2012;18(17):4526\u201337.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"577_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/09513590.2017.1296425","volume":"33","author":"K Dambala","year":"2017","unstructured":"Dambala K, Vavilis D, Bili E, Goulis DG, Tarlatzis BC. Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome. Gynecol Endocrinol. 2017;33(7):529\u201333.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"577_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1177\/0003319719840091","volume":"70","author":"K Dambala","year":"2019","unstructured":"Dambala K, Paschou SA, Michopoulos A, Siasos G, Goulis DG, Vavilis D, et al. Biomarkers of endothelial dysfunction in women with polycystic ovary syndrome. Angiology. 2019;70(9):797\u2013801.","journal-title":"Angiology."},{"issue":"3","key":"577_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humrep\/13.3.651","volume":"13","author":"R Agrawal","year":"1998","unstructured":"Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 1998;13(3):651\u20135.","journal-title":"Hum Reprod"},{"issue":"6","key":"577_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64322-2","volume":"162","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, et al. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol. 2003;162(6):1881\u201393.","journal-title":"Am J Pathol"},{"key":"577_CR20","doi-asserted-by":"crossref","unstructured":"Almawi WY, Gammoh E, Malalla ZH, Al-Madhi SA. Analysis of VEGFA variants and changes in VEGF levels underscores the contribution of VEGF to polycystic ovary syndrome. PloS one. 2016;11(11):e0165636.","DOI":"10.1371\/journal.pone.0165636"},{"key":"577_CR21","doi-asserted-by":"crossref","unstructured":"Bao L, Syed R, Aloahd MS. Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients. Mol Biol Rep. 2019;46(6):5821-9.","DOI":"10.1007\/s11033-019-05015-y"},{"key":"577_CR22","doi-asserted-by":"crossref","unstructured":"Ben, Salem A, Megdich F, Kacem O, Souayeh M, Hachani Ben Ali F, Hizem S, et al. Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population. BMC Genomics. 2016;17(Suppl 9):748.","DOI":"10.1186\/s12864-016-3092-5"},{"issue":"10","key":"577_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/09513590.2019.1604659","volume":"35","author":"MKDO Gomes","year":"2019","unstructured":"Gomes MKDO, Antonino DDC, Balarin MAS, Tanaka SCSV, Caldeira MA, Trov\u00f3 de Marqui AB, et al. Haplotype analysis of VEGF gene polymorphisms in polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(10):847\u201350.","journal-title":"Gynecol Endocrinol"},{"issue":"10","key":"577_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10815-014-0310-4","volume":"31","author":"P Guruvaiah","year":"2014","unstructured":"Guruvaiah P, Govatati S, Reddy TV, Lomada D, Deenadayal M, Shivaji S, et al. The VEGF +405 G>C 5\u2032 untranslated region polymorphism and risk of PCOS: a study in the south Indian women. J Assist Reprod Genet. 2014;31(10):1383\u20139.","journal-title":"J Assist Reprod Genet"},{"issue":"8","key":"577_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/09513590.2019.1579789","volume":"35","author":"X Huang","year":"2019","unstructured":"Huang X, Hao YL, Zhen XL, Zhou RM, Wang N, Cao SR, et al. Association between the vascular endothelial growth factor gene polymorphisms and the risk of polycystic ovary syndrome in northern Chinese women. Gynecol Endocrinol. 2019;35(8):706\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"577_CR26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.fertnstert.2007.06.049","volume":"89","author":"EJ Lee","year":"2008","unstructured":"Lee EJ, Oh B, Lee JY, Kimm K, Park JM, Baek KH. Association study between single nucleotide polymorphisms in the VEGF gene and polycystic ovary syndrome. Fertil Steril. 2008;89(6):1751\u20139.","journal-title":"Fertil Steril"},{"issue":"1","key":"577_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.06.026","volume":"147","author":"P Vural","year":"2009","unstructured":"Vural P, Kusku-Kiraz Z, Dogru-Abbasoglu S, Cil E, Karadag B, Akgul C, et al. Vascular endothelial growth factor-2578 A\/C,-460 T\/C and+405 G\/C polymorphisms in polycystic ovary syndrome. Eur J Obstetrics Gynecol Reprod Biol. 2009;147(1):57\u201360.","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"issue":"11","key":"577_CR28","first-page":"805","volume":"18","author":"X Ding","year":"2009","unstructured":"Ding X, Yin F. Gene single nucleotide polymorphisms of VEGF and the susceptibility for polycystic ovary syndrome. Progress Obstetrics Gynecol. 2009;18(11):805\u20138.","journal-title":"Progress Obstetrics Gynecol"},{"issue":"14","key":"577_CR29","first-page":"94","volume":"33","author":"N Li","year":"2014","unstructured":"Li N, Yang Q, Zhao M. Aassociation between VEGF gene polymorphisms and polycystic ovary syndrome. China Foreign Med Treat. 2014;33(14):94\u20136.","journal-title":"China Foreign Med Treat"},{"issue":"1","key":"577_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"12","key":"577_CR31","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and Pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2. Endocrine Pract. 2015;21(12):1415\u201326.","journal-title":"Endocrine Pract"},{"issue":"11","key":"577_CR32","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American association of clinical endocrinologists, American college of endocrinology, and androgen excess and Pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--part 1. Endocrine Pract. 2015;21(11):1291\u2013300.","journal-title":"Endocrine Pract"},{"issue":"9","key":"577_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2013.03.003","volume":"66","author":"L Hartling","year":"2013","unstructured":"Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, et al. Testing the Newcastle Ottawa scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013;66(9):982\u201393.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"577_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2009","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive--trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287\u201398.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"577_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-0035-1552582","volume":"33","author":"R Tal","year":"2015","unstructured":"Tal R, Seifer DB, Arici A. The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome. Semin Reprod Med. 2015;33(3):195\u2013207.","journal-title":"Semin Reprod Med"},{"issue":"10","key":"577_CR36","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00018-013-1276-6","volume":"70","author":"JL Thomas","year":"2013","unstructured":"Thomas JL, Eichmann A. The power of VEGF (vascular endothelial growth factor) family molecules. Cell Mol Life Sci. 2013;70(10):1673\u20134.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"577_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56(4):549\u201380.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"577_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/ATVBAHA.108.179663","volume":"29","author":"N Ferrara","year":"2009","unstructured":"Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2009;29(6):789\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"577_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000046610","volume":"106","author":"N Ferrara","year":"2001","unstructured":"Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 2001;106(4):148\u201356.","journal-title":"Acta Haematol"},{"issue":"6","key":"577_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0015-0282(02)04242-5","volume":"78","author":"R Agrawal","year":"2002","unstructured":"Agrawal R, Jacobs H, Payne N, Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril. 2002;78(6):1164\u20139.","journal-title":"Fertil Steril"},{"issue":"6","key":"577_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000054076","volume":"37","author":"W Renner","year":"2000","unstructured":"Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37(6):443\u20138.","journal-title":"J Vasc Res"},{"issue":"8","key":"577_CR42","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1006\/cyto.2000.0692","volume":"12","author":"CJ Watson","year":"2000","unstructured":"Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000;12(8):1232\u20135.","journal-title":"Cytokine."},{"issue":"9","key":"577_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3048","volume":"20","author":"YW Jung","year":"2018","unstructured":"Jung YW, Ahn EH, Kim JO, An HJ, Cho SH, Kim YR, et al. Association of genetic polymorphisms in VEGF \u2212460, \u22127 and \u2212583 and hematocrit level with the development of idiopathic recurrent pregnancy loss and a meta-analysis. J Gene Med. 2018;20(9):e3048.","journal-title":"J Gene Med"},{"key":"577_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.preghy.2019.05.012","volume":"17","author":"M Su","year":"2019","unstructured":"Su M, Hu Z, Dong C, Xu X. Vascular endothelial growth factor gene polymorphisms and hypertensive disorder of pregnancy: a meta-analysis. Pregnancy Hypertens. 2019;17:191\u20136.","journal-title":"Pregnancy Hypertens"},{"key":"577_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejogrb.2017.03.003","volume":"211","author":"Y Sun","year":"2017","unstructured":"Sun Y, Chen M, Mao B, Cheng X, Zhang X, Xu C. Association between vascular endothelial growth factor polymorphism and recurrent pregnancy loss: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;211:169\u201376.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-020-00577-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-020-00577-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:09:52Z","timestamp":1615248592000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-020-00577-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1186\/s12958-020-00577-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}